{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "a - synuclein",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "P",
                    "position": "30"
                },
                "variant_string_id": "a - synuclein A30P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Abnormal accumulation of a - synuclein in Lewy bodies is a neuropathological hallmark of both sporadic and familial Parkinson's disease (PD). Mutations in a - synuclein (A30P and A53T) cause familial autosomal dominant PD, which shares many phenotypic similarities to sporadic PD, including deposition of a - synuclein in Lewy bodies. The presynaptic protein a - synuclein is a major component of Lewy bodies, where it is present in fibrillar forms. Formation of a - synuclein positive inclusions is also seen in other synucleinopathies.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that abnormal a - synuclein accumulation in Lewy bodies is a key neuropathological feature of PD and that A30P mutation in a - synuclein causes familial autosomal dominant PD, thus defining the disease mechanism related to the variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "We used stable human neuronal cell lines (BE2 - M17) over - expressing wild - type or mutant human a - synuclein, to monitor global alterations in gene expression levels using the Affymetrix U95A oligonucleotide array. We also used quantitative RT - PCR and Western blotting to confirm gene expression changes at the mRNA and protein levels respectively.",
                    "judgment": "Yes",
                    "reasoning": "The use of cell lines to study gene expression alterations and confirmation by RT - PCR and Western blotting are relevant methods as they can reflect the cellular and molecular changes associated with the disease mechanism defined in Step 1. These assays can model how the A30P variant may affect gene expression and protein levels in the context of PD pathogenesis.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For microarray analysis, total RNA was isolated from clonal cell lines and hybridized to Affymetrix U95A oligonucleotide arrays. Pairwise comparisons with the vector - only cell line were carried out. For quantitative RT - PCR, reactions were performed in quadruplicate and confirmed on at least two separate reaction plates. Western blotting was done with appropriate primary and secondary antibodies and blots were reprobed with b - actin to verify equal loading.",
                    "sub_step": "3a: Basic Controls and Replicates",
                    "judgment": "Yes",
                    "reasoning": "For microarray, a vector - only cell line was used as a control. For RT - PCR, multiple replicates (quadruplicate reactions on at least two separate plates) were used. In Western blotting, b - actin was used as a loading control. Both normal (vector - only) and in a sense, abnormal (mutant - expressing) conditions were compared, fulfilling the requirements of basic controls. Thus, both basic control and replicate conditions are met.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "No information on the use of known pathogenic or benign variants as controls for the A30P variant.",
                    "sub_step": "3c: Variant Controls",
                    "judgment": "No",
                    "reasoning": "The paper does not mention the use of known pathogenic or benign variants as controls, nor variants that reach P/LP or B/LB criteria without relying on PS3/BS3 evidence for the A30P variant.",
                    "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The A30P variant in a - synuclein was associated with PD. The study defined the disease mechanism, and the assays used were applicable. Although basic controls and replicates were present, no variant controls were used. Hence, the functional evidence strength is PS3_supporting."
        },
        {
            "variant_id": {
                "Gene": "a - synuclein",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "T",
                    "position": "53"
                },
                "variant_string_id": "a - synuclein A53T"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Abnormal accumulation of a - synuclein in Lewy bodies is a neuropathological hallmark of both sporadic and familial Parkinson's disease (PD). Mutations in a - synuclein (A30P and A53T) cause familial autosomal dominant PD, which shares many phenotypic similarities to sporadic PD, including deposition of a - synuclein in Lewy bodies. The presynaptic protein a - synuclein is a major component of Lewy bodies, where it is present in fibrillar forms. Formation of a - synuclein positive inclusions is also seen in other synucleinopathies.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines that A53T mutation in a - synuclein causes familial autosomal dominant PD with similar neuropathological features as sporadic PD, thus establishing the disease mechanism related to the variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "We used stable human neuronal cell lines (BE2 - M17) over - expressing wild - type or mutant human a - synuclein, to monitor global alterations in gene expression levels using the Affymetrix U95A oligonucleotide array. We also used quantitative RT - PCR and Western blotting to confirm gene expression changes at the mRNA and protein levels respectively.",
                    "judgment": "Yes",
                    "reasoning": "The assays of using cell lines for gene expression analysis, along with RT - PCR and Western blotting for confirmation, are applicable as they can capture the molecular and cellular changes relevant to the PD pathogenesis associated with the A53T variant.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For microarray analysis, total RNA was isolated from clonal cell lines and hybridized to Affymetrix U95A oligonucleotide arrays. Pairwise comparisons with the vector - only cell line were carried out. For quantitative RT - PCR, reactions were performed in quadruplicate and confirmed on at least two separate reaction plates. Western blotting was done with appropriate primary and secondary antibodies and blots were reprobed with b - actin to verify equal loading.",
                    "sub_step": "3a: Basic Controls and Replicates",
                    "judgment": "Yes",
                    "reasoning": "A vector - only cell line was used as a control in microarray, multiple replicates were used in RT - PCR, and b - actin was used as a loading control in Western blotting. Normal (vector - only) and abnormal (mutant - expressing) conditions were compared, fulfilling basic control requirements. Thus, both basic control and replicate conditions are met.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "No information on the use of known pathogenic or benign variants as controls for the A53T variant.",
                    "sub_step": "3c: Variant Controls",
                    "judgment": "No",
                    "reasoning": "The paper does not mention the use of known pathogenic or benign variants as controls, nor variants that reach P/LP or B/LB criteria without relying on PS3/BS3 evidence for the A53T variant.",
                    "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The A53T variant in a - synuclein is related to PD. The disease mechanism was defined, and the assays were applicable. With basic controls and replicates present but no variant controls, the functional evidence strength is PS3_supporting."
        }
    ]
}